首页 > 最新文献

Cellular signalling最新文献

英文 中文
Trps1 enhances Hdac4 and Gli3 protein stability and nuclear localization independent of PKA and PP2A signaling Trps1增强Hdac4和Gli3蛋白的稳定性和核定位,不依赖于PKA和PP2A信号。
IF 3.7 2区 生物学 Q2 CELL BIOLOGY Pub Date : 2025-12-11 DOI: 10.1016/j.cellsig.2025.112301
Manuela Wuelling , Lara M. Janz , Anja B. Ende , Nina Schulze , Andrea Vortkamp
The growth of endochondral bones relies on the coordinated proliferation and hypertrophy of chondrocytes. This process is governed by several transcription factors and epigenetic modifiers that regulate distinct steps, likely by assembling into larger complexes that bind to DNA. The transcription factor Trps1 has previously been shown to interact with the activator form of Gli3 (Gli3A) and the histone deacetylase Hdac4, two critical regulators of chondrocytes proliferation and differentiation. Here, we show that the interaction with Trps1 increases the abundance of both proteins and promotes their nuclear localization. We further demonstrate that Trps1 acts independently of PKA and PP2A activity, which have been reported to regulate the nuclear localization and activity of Gli3A and Hdac4. Trps1 and Gli3A complexes were predominantly found in proliferating chondrocytes, whereas Trps1 and Hdac4 interactions occurred more frequently in prehypertrophic chondrocytes, suggesting differentiation-specific changes in protein interactions. These findings reveal the regulation of protein abundance and nuclear availability as a novel mechanism by which Trps1 controls gene expression during chondrocyte differentiation.
软骨内骨的生长依赖于软骨细胞的协调增殖和肥大。这个过程是由几个转录因子和表观遗传修饰因子控制的,这些转录因子和表观遗传修饰因子调节不同的步骤,可能通过组装成更大的结合DNA的复合物。转录因子Trps1先前已被证明与Gli3的激活因子形式(Gli3A)和组蛋白去乙酰化酶Hdac4相互作用,这是软骨细胞增殖和分化的两个关键调节因子。在这里,我们发现与Trps1的相互作用增加了这两种蛋白的丰度,并促进了它们的核定位。我们进一步证明Trps1独立于PKA和PP2A活性起作用,而PKA和PP2A已被报道调节Gli3A和Hdac4的核定位和活性。Trps1和Gli3A复合物主要存在于增殖软骨细胞中,而Trps1和Hdac4相互作用更频繁地发生在肥大前软骨细胞中,提示蛋白质相互作用的分化特异性变化。这些发现揭示了Trps1在软骨细胞分化过程中调控蛋白丰度和核可用性的新机制。
{"title":"Trps1 enhances Hdac4 and Gli3 protein stability and nuclear localization independent of PKA and PP2A signaling","authors":"Manuela Wuelling ,&nbsp;Lara M. Janz ,&nbsp;Anja B. Ende ,&nbsp;Nina Schulze ,&nbsp;Andrea Vortkamp","doi":"10.1016/j.cellsig.2025.112301","DOIUrl":"10.1016/j.cellsig.2025.112301","url":null,"abstract":"<div><div>The growth of endochondral bones relies on the coordinated proliferation and hypertrophy of chondrocytes. This process is governed by several transcription factors and epigenetic modifiers that regulate distinct steps, likely by assembling into larger complexes that bind to DNA. The transcription factor Trps1 has previously been shown to interact with the activator form of Gli3 (Gli3A) and the histone deacetylase Hdac4, two critical regulators of chondrocytes proliferation and differentiation. Here, we show that the interaction with Trps1 increases the abundance of both proteins and promotes their nuclear localization. We further demonstrate that Trps1 acts independently of PKA and PP2A activity, which have been reported to regulate the nuclear localization and activity of Gli3A and Hdac4. Trps1 and Gli3A complexes were predominantly found in proliferating chondrocytes, whereas Trps1 and Hdac4 interactions occurred more frequently in prehypertrophic chondrocytes, suggesting differentiation-specific changes in protein interactions. These findings reveal the regulation of protein abundance and nuclear availability as a novel mechanism by which Trps1 controls gene expression during chondrocyte differentiation.</div></div>","PeriodicalId":9902,"journal":{"name":"Cellular signalling","volume":"139 ","pages":"Article 112301"},"PeriodicalIF":3.7,"publicationDate":"2025-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145751784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ED-71 prevents glucocorticoid-induced bone loss by inhibiting type H vascular endothelial cell senescence through maintaining mitochondria-associated membrane-mediated calcium homeostasis ED-71通过维持线粒体相关膜介导的钙稳态,抑制H型血管内皮细胞衰老,从而预防糖皮质激素诱导的骨质流失。
IF 3.7 2区 生物学 Q2 CELL BIOLOGY Pub Date : 2025-12-08 DOI: 10.1016/j.cellsig.2025.112298
Xiaorui Wang , Weidong Zhang , Ting Liu , Xing Rong , Qinghua Ren , Shibing Guan , Minqi Li
Glucocorticoids (GCs) are widely used in anti-inflammatory and immunosuppressive therapies. However, long-term or high-dose administration of GCs often leads to bone loss, resulting in GC-induced osteoporosis (GIOP). GIOP reduces bone strength, increases fracture risk, and affects the quality of life and treatment compliance of patients. Therefore, there is an urgent need to develop new therapeutic drugs for GIOP. This study found that the active vitamin D analog eldecalcitol (ED-71) can prevent GIOP by inhibiting vascular endothelial cells (ECs) senescence and improving angiogenesis and osteogenesis. Dexamethasone (DEX) induces senescence of type H vascular ECs by promoting mitochondrial calcium overload mediated by mitochondrial-associated membranes (MAMs). ED-71 regulates glucose-regulated protein 75 (GRP75) through the vitamin D receptor (VDR)-protein kinase C (PKC) signaling pathway, reduces MAM-mediated mitochondrial calcium overload, inhibits senescence of ECs, and restores the angiogenesis-osteogenesis coupling mechanism, thereby ameliorating bone loss. This study reveals a new mechanism by which ED-71 ameliorates GIOP, by maintaining MAM-mediated mitochondrial calcium homeostasis to reduce vascular bone disease. This finding not only provides theoretical support for the application of ED-71 in the prevention and treatment of GIOP but also offers important theoretical basis for the development of MAM-targeted drugs for osteoporosis, as well as suggestions for potential therapeutic targets.
糖皮质激素广泛应用于抗炎和免疫抑制治疗。然而,长期或大剂量服用gc往往会导致骨质流失,导致gc诱导的骨质疏松症(GIOP)。GIOP降低骨强度,增加骨折风险,影响患者的生活质量和治疗依从性。因此,迫切需要开发新的GIOP治疗药物。本研究发现,活性维生素D类似物eldecalcitol (ED-71)可通过抑制血管内皮细胞(ECs)衰老,促进血管生成和骨生成来预防GIOP。地塞米松(DEX)通过促进线粒体相关膜(MAMs)介导的线粒体钙超载诱导H型血管内皮细胞衰老。ED-71通过维生素D受体(VDR)-蛋白激酶C (PKC)信号通路调控葡萄糖调节蛋白75 (GRP75),减少mam介导的线粒体钙超载,抑制内皮细胞衰老,恢复血管生成-成骨耦合机制,从而改善骨质流失。本研究揭示了ED-71通过维持mam介导的线粒体钙稳态来减少血管性骨病,从而改善GIOP的新机制。这一发现不仅为ED-71在预防和治疗GIOP中的应用提供了理论支持,也为开发mam靶向的骨质疏松药物提供了重要的理论依据,并对潜在的治疗靶点提出了建议。
{"title":"ED-71 prevents glucocorticoid-induced bone loss by inhibiting type H vascular endothelial cell senescence through maintaining mitochondria-associated membrane-mediated calcium homeostasis","authors":"Xiaorui Wang ,&nbsp;Weidong Zhang ,&nbsp;Ting Liu ,&nbsp;Xing Rong ,&nbsp;Qinghua Ren ,&nbsp;Shibing Guan ,&nbsp;Minqi Li","doi":"10.1016/j.cellsig.2025.112298","DOIUrl":"10.1016/j.cellsig.2025.112298","url":null,"abstract":"<div><div>Glucocorticoids (GCs) are widely used in anti-inflammatory and immunosuppressive therapies. However, long-term or high-dose administration of GCs often leads to bone loss, resulting in GC-induced osteoporosis (GIOP). GIOP reduces bone strength, increases fracture risk, and affects the quality of life and treatment compliance of patients. Therefore, there is an urgent need to develop new therapeutic drugs for GIOP. This study found that the active vitamin D analog eldecalcitol (ED-71) can prevent GIOP by inhibiting vascular endothelial cells (ECs) senescence and improving angiogenesis and osteogenesis. Dexamethasone (DEX) induces senescence of type H vascular ECs by promoting mitochondrial calcium overload mediated by mitochondrial-associated membranes (MAMs). ED-71 regulates glucose-regulated protein 75 (GRP75) through the vitamin D receptor (VDR)-protein kinase C (PKC) signaling pathway, reduces MAM-mediated mitochondrial calcium overload, inhibits senescence of ECs, and restores the angiogenesis-osteogenesis coupling mechanism, thereby ameliorating bone loss. This study reveals a new mechanism by which ED-71 ameliorates GIOP, by maintaining MAM-mediated mitochondrial calcium homeostasis to reduce vascular bone disease. This finding not only provides theoretical support for the application of ED-71 in the prevention and treatment of GIOP but also offers important theoretical basis for the development of MAM-targeted drugs for osteoporosis, as well as suggestions for potential therapeutic targets.</div></div>","PeriodicalId":9902,"journal":{"name":"Cellular signalling","volume":"139 ","pages":"Article 112298"},"PeriodicalIF":3.7,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145721407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gentianine suppresses renal cell carcinoma progression via direct interaction with KDM5B and ferroptosis activation 龙胆碱通过与KDM5B和铁下垂激活的直接相互作用抑制肾细胞癌的进展。
IF 3.7 2区 生物学 Q2 CELL BIOLOGY Pub Date : 2025-12-08 DOI: 10.1016/j.cellsig.2025.112300
Jintao Wu , Xiangrong Ying , Yu Ren , Gangfeng Wu , Zhenggang Luo , Chong Shen , Zhenghao Zhang , Haojie Zhang
Gentianine (GTN), a bioactive alkaloid isolated from Gentiana scabra Bunge, exhibits broad therapeutic potential in inflammatory and metabolic diseases, yet its antitumor properties and molecular mechanisms in renal cell carcinoma (RCC) remain unexplored. In this study, we demonstrate that GTN significantly inhibits RCC cell proliferation and metastasis in vitro and suppresses tumor growth in xenograft models. Mechanistic investigations revealed that GTN directly interacts with the histone demethylase KDM5B, preventing its degradation. The increased KDM5B expression decreased H3K4me3 level at the promoters of ferroptosis-related genes GPX4 and SLC7A11, leading to transcriptional repression of these antioxidant regulators. Consequently, GTN induces ferroptosis hallmarks, including glutathione (GSH) depletion, iron-dependent lipid peroxidation, and mitochondrial dysfunction. Importantly, combining GTN with the ferroptosis inducer RSL3 synergistically enhances antitumor efficacy in vivo. Our study unveils a previously unrecognized KDM5B/ferroptosis axis through which GTN exerts its antitumor effects, positioning GTN as a promising lead compound for ferroptosis-targeted therapy in RCC.
龙胆草碱(gentiine, GTN)是一种从龙胆草(Gentiana scabra Bunge)中分离出来的生物活性生物碱,在炎症和代谢疾病中具有广泛的治疗潜力,但其抗肿瘤特性和在肾细胞癌(RCC)中的分子机制尚不清楚。在本研究中,我们证明GTN在体外显著抑制RCC细胞的增殖和转移,并抑制异种移植模型中的肿瘤生长。机制研究表明,GTN直接与组蛋白去甲基化酶KDM5B相互作用,阻止其降解。KDM5B表达的增加降低了铁衰相关基因GPX4和SLC7A11启动子上的H3K4me3水平,导致这些抗氧化调节因子的转录抑制。因此,GTN诱导铁下垂的特征,包括谷胱甘肽(GSH)耗竭、铁依赖性脂质过氧化和线粒体功能障碍。重要的是,GTN与铁下垂诱导剂RSL3联合使用可协同提高体内抗肿瘤效果。我们的研究揭示了一个以前未被识别的KDM5B/铁下垂轴,GTN通过该轴发挥其抗肿瘤作用,将GTN定位为RCC铁下垂靶向治疗的有希望的先导化合物。
{"title":"Gentianine suppresses renal cell carcinoma progression via direct interaction with KDM5B and ferroptosis activation","authors":"Jintao Wu ,&nbsp;Xiangrong Ying ,&nbsp;Yu Ren ,&nbsp;Gangfeng Wu ,&nbsp;Zhenggang Luo ,&nbsp;Chong Shen ,&nbsp;Zhenghao Zhang ,&nbsp;Haojie Zhang","doi":"10.1016/j.cellsig.2025.112300","DOIUrl":"10.1016/j.cellsig.2025.112300","url":null,"abstract":"<div><div>Gentianine (GTN), a bioactive alkaloid isolated from Gentiana scabra Bunge, exhibits broad therapeutic potential in inflammatory and metabolic diseases, yet its antitumor properties and molecular mechanisms in renal cell carcinoma (RCC) remain unexplored. In this study, we demonstrate that GTN significantly inhibits RCC cell proliferation and metastasis in vitro and suppresses tumor growth in xenograft models. Mechanistic investigations revealed that GTN directly interacts with the histone demethylase KDM5B, preventing its degradation. The increased KDM5B expression decreased H3K4me3 level at the promoters of ferroptosis-related genes GPX4 and SLC7A11, leading to transcriptional repression of these antioxidant regulators. Consequently, GTN induces ferroptosis hallmarks, including glutathione (GSH) depletion, iron-dependent lipid peroxidation, and mitochondrial dysfunction. Importantly, combining GTN with the ferroptosis inducer RSL3 synergistically enhances antitumor efficacy in vivo. Our study unveils a previously unrecognized KDM5B/ferroptosis axis through which GTN exerts its antitumor effects, positioning GTN as a promising lead compound for ferroptosis-targeted therapy in RCC.</div></div>","PeriodicalId":9902,"journal":{"name":"Cellular signalling","volume":"139 ","pages":"Article 112300"},"PeriodicalIF":3.7,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145721444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SYT15B promotes tumor progression through interaction with IQGAP1 to activate the MAPK pathway in lung adenocarcinoma SYT15B在肺腺癌中通过与IQGAP1相互作用激活MAPK通路促进肿瘤进展。
IF 3.7 2区 生物学 Q2 CELL BIOLOGY Pub Date : 2025-12-07 DOI: 10.1016/j.cellsig.2025.112302
Yue Ren , Tianyi Li , Heng Zhou , Yuqing Cui , Chenghao Li , Weigan Shen , Haibo Sun , Haiyan Mao , Zhengrong Zhang , Zheng Wang , Zhi Ling , Yong Chen , Xudong Yin
Lung adenocarcinoma (LUAD) the predominant subtype of lung cancer, is characterized by rapid tumor growth, local invasion, and distant metastasis. Since dysregulated expression of synaptotagmin (SYT) proteins have been implicated in the development and progression of LUAD, the specific role and mechanisms of SYT15B in LUAD remain unclear. This study demonstrates that elevated SYT15B expression drives malignant progression and predicts poor prognosis in LUAD, as evidenced by integrated clinical sample, in vitro, and in vivo analyses. We identify a novel molecular mechanism whereby SYT15B interacts with IQ motif-containing GTPase-activating protein 1 (IQGAP1), leading to activation of the MAPK signalling pathway and subsequent promotion of aggressive tumor phenotypes. Disruption of the SYT15B-IQGAP1 interaction through IQGAP1 knockdown attenuated MAPK signalling pathway activation and reversed the oncogenic phenotype induced by SYT15B. Notably, specific inhibition of intracellular calcium with BAPTA can also attenuates SYT15B-IQGAP1 complex formation, abrogates MAPK signalling activation, and reverses SYT15B-mediated oncogenic effects. These findings establish the calcium-dependent SYT15B/IQGAP1/MAPK axis as a potential therapeutic and prognostic biomarker in LUAD.
肺腺癌(LUAD)是肺癌的主要亚型,其特点是肿瘤生长迅速、局部侵袭和远处转移。由于SYT蛋白表达失调与LUAD的发生和发展有关,SYT15B在LUAD中的具体作用和机制尚不清楚。本研究通过综合临床样本、体外和体内分析表明,SYT15B表达升高可推动LUAD的恶性进展,并预测预后不良。我们发现了一种新的分子机制,即SYT15B与含有IQ基序的gtpase激活蛋白1 (IQGAP1)相互作用,导致MAPK信号通路的激活,并随后促进侵袭性肿瘤表型。通过IQGAP1敲低干扰SYT15B-IQGAP1相互作用可减弱MAPK信号通路的激活,逆转SYT15B诱导的致癌表型。值得注意的是,用BAPTA特异性抑制细胞内钙也可以减弱SYT15B-IQGAP1复合物的形成,消除MAPK信号激活,逆转syt15b介导的致癌作用。这些发现确立了钙依赖性SYT15B/IQGAP1/MAPK轴作为LUAD潜在的治疗和预后生物标志物。
{"title":"SYT15B promotes tumor progression through interaction with IQGAP1 to activate the MAPK pathway in lung adenocarcinoma","authors":"Yue Ren ,&nbsp;Tianyi Li ,&nbsp;Heng Zhou ,&nbsp;Yuqing Cui ,&nbsp;Chenghao Li ,&nbsp;Weigan Shen ,&nbsp;Haibo Sun ,&nbsp;Haiyan Mao ,&nbsp;Zhengrong Zhang ,&nbsp;Zheng Wang ,&nbsp;Zhi Ling ,&nbsp;Yong Chen ,&nbsp;Xudong Yin","doi":"10.1016/j.cellsig.2025.112302","DOIUrl":"10.1016/j.cellsig.2025.112302","url":null,"abstract":"<div><div>Lung adenocarcinoma (LUAD) the predominant subtype of lung cancer, is characterized by rapid tumor growth, local invasion, and distant metastasis. Since dysregulated expression of synaptotagmin (SYT) proteins have been implicated in the development and progression of LUAD, the specific role and mechanisms of SYT15B in LUAD remain unclear. This study demonstrates that elevated SYT15B expression drives malignant progression and predicts poor prognosis in LUAD, as evidenced by integrated clinical sample, <em>in vitro</em>, and <em>in vivo</em> analyses. We identify a novel molecular mechanism whereby SYT15B interacts with IQ motif-containing GTPase-activating protein 1 (IQGAP1), leading to activation of the MAPK signalling pathway and subsequent promotion of aggressive tumor phenotypes. Disruption of the SYT15B-IQGAP1 interaction through IQGAP1 knockdown attenuated MAPK signalling pathway activation and reversed the oncogenic phenotype induced by SYT15B. Notably, specific inhibition of intracellular calcium with BAPTA can also attenuates SYT15B-IQGAP1 complex formation, abrogates MAPK signalling activation, and reverses SYT15B-mediated oncogenic effects. These findings establish the calcium-dependent SYT15B/IQGAP1/MAPK axis as a potential therapeutic and prognostic biomarker in LUAD.</div></div>","PeriodicalId":9902,"journal":{"name":"Cellular signalling","volume":"139 ","pages":"Article 112302"},"PeriodicalIF":3.7,"publicationDate":"2025-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145713563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Decoding COPD-related cognitive impairment: The protective potential of YTHDF1 解码copd相关认知障碍:YTHDF1的保护潜力。
IF 3.7 2区 生物学 Q2 CELL BIOLOGY Pub Date : 2025-12-07 DOI: 10.1016/j.cellsig.2025.112311
Keke Lu , Yuanyuan Qu , Ruohuan Shi , Chao Wu , Tao Xu
Cognitive impairment is a significant complication in individuals with chronic obstructive pulmonary disease (COPD), which presents a substantial challenge to future healthcare resource allocation. However, the underlying therapeutic targets and mechanisms remain inadequately understood. In a study involving mice with COPD, hippocampal damage and deficits in working memory, spatial learning, and memory capabilities were observed following prolonged exposure to cigarette smoke (CS). CS exposure was found to induce apoptosis in hippocampal cells in vivo. Western blot and RT-qPCR analyses demonstrated a marked reduction in the expression of the m6A RNA-binding protein YTHDF1 compared to the control group. In vitro experiments related to the brain damage mechanism of COPD demonstrated a significant decrease in the level of YTHDF1 under hypoxic conditions. Notably, the overexpression of YTHDF1 mitigated hypoxia-induced apoptosis in HT22 cells. Furthermore, the overexpression of YTHDF1 attenuated cognitive impairment by reducing hippocampal neuronal apoptosis induced by CS. The findings suggest that YTHDF1 could have a substantial impact on cognitive dysfunction induced by COPD. Hypoxic conditions within hippocampal tissue may significantly contribute to this process, offering novel insights into the molecular mechanisms underlying COPD-related cognitive impairment.
认知障碍是慢性阻塞性肺疾病(COPD)患者的重要并发症,对未来的医疗资源分配提出了重大挑战。然而,潜在的治疗靶点和机制仍然不充分了解。在一项涉及COPD小鼠的研究中,观察到长时间暴露于香烟烟雾(CS)后海马损伤和工作记忆、空间学习和记忆能力的缺陷。CS暴露在体内可诱导海马细胞凋亡。Western blot和RT-qPCR分析显示,与对照组相比,m6A rna结合蛋白YTHDF1的表达明显减少。体外COPD脑损伤机制相关实验显示,缺氧条件下YTHDF1水平显著降低。值得注意的是,YTHDF1的过表达减轻了缺氧诱导的HT22细胞凋亡。此外,YTHDF1的过表达通过减少CS诱导的海马神经元凋亡来减轻认知功能障碍。研究结果表明,YTHDF1可能对COPD引起的认知功能障碍有重大影响。海马组织内的缺氧条件可能对这一过程有重要影响,为copd相关认知障碍的分子机制提供了新的见解。
{"title":"Decoding COPD-related cognitive impairment: The protective potential of YTHDF1","authors":"Keke Lu ,&nbsp;Yuanyuan Qu ,&nbsp;Ruohuan Shi ,&nbsp;Chao Wu ,&nbsp;Tao Xu","doi":"10.1016/j.cellsig.2025.112311","DOIUrl":"10.1016/j.cellsig.2025.112311","url":null,"abstract":"<div><div>Cognitive impairment is a significant complication in individuals with chronic obstructive pulmonary disease (COPD), which presents a substantial challenge to future healthcare resource allocation. However, the underlying therapeutic targets and mechanisms remain inadequately understood. In a study involving mice with COPD, hippocampal damage and deficits in working memory, spatial learning, and memory capabilities were observed following prolonged exposure to cigarette smoke (CS). CS exposure was found to induce apoptosis in hippocampal cells in vivo. Western blot and RT-qPCR analyses demonstrated a marked reduction in the expression of the m6A RNA-binding protein YTHDF1 compared to the control group. In vitro experiments related to the brain damage mechanism of COPD demonstrated a significant decrease in the level of YTHDF1 under hypoxic conditions. Notably, the overexpression of YTHDF1 mitigated hypoxia-induced apoptosis in HT22 cells. Furthermore, the overexpression of YTHDF1 attenuated cognitive impairment by reducing hippocampal neuronal apoptosis induced by CS. The findings suggest that YTHDF1 could have a substantial impact on cognitive dysfunction induced by COPD. Hypoxic conditions within hippocampal tissue may significantly contribute to this process, offering novel insights into the molecular mechanisms underlying COPD-related cognitive impairment.</div></div>","PeriodicalId":9902,"journal":{"name":"Cellular signalling","volume":"139 ","pages":"Article 112311"},"PeriodicalIF":3.7,"publicationDate":"2025-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145713479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reprogramming mitochondrial homeostasis in renal ischemia–reperfusion injury 肾缺血再灌注损伤中线粒体稳态重编程。
IF 3.7 2区 生物学 Q2 CELL BIOLOGY Pub Date : 2025-12-06 DOI: 10.1016/j.cellsig.2025.112294
Kangyu Wang , Hao Wang , Yalong Zhang , Zijian Zhang , Li Wang , Jianwei Yang , Jiangwei Man , Li Yang
Acute kidney injury (AKI) caused by renal ischemia–reperfusion injury (RIRI) is primarily a mitochondrial disorder characterized by disrupted dynamics, impaired biogenesis, and defective quality control. Excessive DRP1-mediated fission, suppression of the AMPK–SIRT–PGC-1α axis, and failure of the PINK1–Parkin mitophagy system converge to drive tubular dysfunction and ferroptosis. Here, we integrate recent insights into a “mitochondrial reprogramming” framework encompassing three axes—dynamic remodeling, metabolic renewal, and proteostatic reinforcement. Therapeutic strategies targeting these axes, such as DRP1 inhibition, AMPK–SIRT–PGC-1α activation, and reinforcement of mitophagy and MAM integrity by agents like melatonin, puerarin, or Schisandrin B, have shown promise in restoring mitochondrial resilience. Furthermore, mitochondrial biomarkers and imaging tools (mtDNA, mitochondrial peptides, [18F]BCPP-EF PET) may enable phenotype-guided interventions. This review outlines the “RIRI–Mitochondria–AKI–CKD continuum,” emphasizing that mitochondrial maladaptation bridges acute injury and chronic fibrosis, highlighting mitochondria as precision therapeutic targets in AKI.
由肾缺血再灌注损伤(RIRI)引起的急性肾损伤(AKI)主要是一种线粒体疾病,其特征是动力学破坏、生物发生受损和质量控制缺陷。过度的drp1介导的裂变,AMPK-SIRT-PGC-1α轴的抑制,以及PINK1-Parkin有丝分裂系统的失败共同驱动小管功能障碍和铁凋亡。在这里,我们将最近的见解整合到“线粒体重编程”框架中,该框架包括三个轴-动态重塑,代谢更新和蛋白质静态强化。针对这些轴的治疗策略,如DRP1抑制,AMPK-SIRT-PGC-1α激活,以及通过褪黑素、葛根素或五味子素B等药物增强线粒体自噬和MAM完整性,已经显示出恢复线粒体弹性的希望。此外,线粒体生物标志物和成像工具(mtDNA,线粒体肽,[18F]BCPP-EF PET)可以实现表型引导干预。这篇综述概述了“riri -线粒体-AKI- ckd连续体”,强调线粒体适应不良是急性损伤和慢性纤维化的桥梁,强调线粒体是AKI的精确治疗靶点。
{"title":"Reprogramming mitochondrial homeostasis in renal ischemia–reperfusion injury","authors":"Kangyu Wang ,&nbsp;Hao Wang ,&nbsp;Yalong Zhang ,&nbsp;Zijian Zhang ,&nbsp;Li Wang ,&nbsp;Jianwei Yang ,&nbsp;Jiangwei Man ,&nbsp;Li Yang","doi":"10.1016/j.cellsig.2025.112294","DOIUrl":"10.1016/j.cellsig.2025.112294","url":null,"abstract":"<div><div>Acute kidney injury (AKI) caused by renal ischemia–reperfusion injury (RIRI) is primarily a mitochondrial disorder characterized by disrupted dynamics, impaired biogenesis, and defective quality control. Excessive DRP1-mediated fission, suppression of the AMPK–SIRT–PGC-1α axis, and failure of the PINK1–Parkin mitophagy system converge to drive tubular dysfunction and ferroptosis. Here, we integrate recent insights into a “mitochondrial reprogramming” framework encompassing three axes—dynamic remodeling, metabolic renewal, and proteostatic reinforcement. Therapeutic strategies targeting these axes, such as DRP1 inhibition, AMPK–SIRT–PGC-1α activation, and reinforcement of mitophagy and MAM integrity by agents like melatonin, puerarin, or Schisandrin B, have shown promise in restoring mitochondrial resilience. Furthermore, mitochondrial biomarkers and imaging tools (mtDNA, mitochondrial peptides, [<sup>18</sup>F]BCPP-EF PET) may enable phenotype-guided interventions. This review outlines the “RIRI–Mitochondria–AKI–CKD continuum,” emphasizing that mitochondrial maladaptation bridges acute injury and chronic fibrosis, highlighting mitochondria as precision therapeutic targets in AKI.</div></div>","PeriodicalId":9902,"journal":{"name":"Cellular signalling","volume":"139 ","pages":"Article 112294"},"PeriodicalIF":3.7,"publicationDate":"2025-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145707658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Far-infrared irradiation suppresses pyroptosis in ischemic flaps through TRPV3-mediated activation of the A2AR/EPAC1/Rap1 signaling pathway 远红外照射通过trpv3介导的A2AR/EPAC1/Rap1信号通路的激活抑制缺血皮瓣的焦亡。
IF 3.7 2区 生物学 Q2 CELL BIOLOGY Pub Date : 2025-12-05 DOI: 10.1016/j.cellsig.2025.112299
Yuqi Wang , Jiaying Lou , Rongfang Dai , Liang Chen , Yi Wang , Yu Wang , Xiangwei Ling , Xiaoqiong Jiang , Fuman Cai
Random pattern skin flaps (RPSFs) are often associated with distal ischemic necrosis, primarily due to inadequate blood perfusion. Although far-infrared (FIR) irradiation has been reported to promote tissue repair, its precise role and underlying mechanisms in ischemic flap survival remain poorly understood. Here, we demonstrated that FIR irradiation enhances ischemic flap survival by activating the Adenosine A2a receptor/Exchange protein activated by cAMP 1/Ras - related protein 1 (A2AR/EPAC1/Rap1) pathway through transient receptor potential cation channel subfamily V member 3 (TRPV3)-mediated Ca2+ influx and subsequent adenosine production, and by suppressing pyroptosis. Transcriptome sequencing indicated that A2AR was reduced in ischemic flaps. Inhibition of A2AR impairs angiogenesis, promotes oxidative stress and pyroptosis, thereby exacerbating ischemia in the flaps. FIR irradiation attenuates pyroptosis through the A2AR/EPAC1/Rap1 pathway, thereby mitigating ischemia in the flaps caused by A2AR deficiency. Furthermore, KEGG pathway analysis revealed that the calcium signaling pathway and transient receptor potential channels play a critical role in ischemic flaps. Silencing TRPV3 in both mice and endothelial cells revealed that FIR upregulated TRPV3 expression, promoted extracellular Ca2+ influx, triggered ATP conversion to adenosine, and subsequently activated A2AR. Overall, this study provides new insights into the therapeutic mechanisms of FIR irradiation in ischemic flaps, offering potential targets for improving the treatment of ischemic flap pathology.
随机皮瓣(RPSFs)通常与远端缺血性坏死有关,主要是由于血液灌注不足。尽管有报道称远红外(FIR)照射可促进组织修复,但其在缺血皮瓣存活中的确切作用和潜在机制尚不清楚。在这里,我们证明了FIR照射通过瞬时受体电位阳离子通道亚家族V成员3 (TRPV3)介导的Ca2+内流和随后的腺苷生成,激活由cAMP 1/Ras相关蛋白1 (A2AR/EPAC1/Rap1)激活的腺苷A2a受体/交换蛋白,并通过抑制焦亡,从而提高缺血皮瓣的存活。转录组测序显示,A2AR在缺血皮瓣中减少。抑制A2AR损害血管生成,促进氧化应激和焦亡,从而加剧皮瓣缺血。FIR照射通过A2AR/EPAC1/Rap1通路减弱焦亡,从而减轻A2AR缺乏引起的皮瓣缺血。此外,KEGG通路分析显示钙信号通路和瞬时受体电位通道在缺血皮瓣中起关键作用。在小鼠和内皮细胞中沉默TRPV3表明,FIR上调TRPV3的表达,促进细胞外Ca2+内流,触发ATP转化为腺苷,随后激活A2AR。总的来说,本研究为FIR照射缺血性皮瓣的治疗机制提供了新的见解,为改善缺血性皮瓣病理治疗提供了潜在的靶点。
{"title":"Far-infrared irradiation suppresses pyroptosis in ischemic flaps through TRPV3-mediated activation of the A2AR/EPAC1/Rap1 signaling pathway","authors":"Yuqi Wang ,&nbsp;Jiaying Lou ,&nbsp;Rongfang Dai ,&nbsp;Liang Chen ,&nbsp;Yi Wang ,&nbsp;Yu Wang ,&nbsp;Xiangwei Ling ,&nbsp;Xiaoqiong Jiang ,&nbsp;Fuman Cai","doi":"10.1016/j.cellsig.2025.112299","DOIUrl":"10.1016/j.cellsig.2025.112299","url":null,"abstract":"<div><div>Random pattern skin flaps (RPSFs) are often associated with distal ischemic necrosis, primarily due to inadequate blood perfusion. Although far-infrared (FIR) irradiation has been reported to promote tissue repair, its precise role and underlying mechanisms in ischemic flap survival remain poorly understood. Here, we demonstrated that FIR irradiation enhances ischemic flap survival by activating the Adenosine A2a receptor/Exchange protein activated by cAMP 1/Ras - related protein 1 (A2AR/EPAC1/Rap1) pathway through transient receptor potential cation channel subfamily V member 3 (TRPV3)-mediated Ca<sup>2+</sup> influx and subsequent adenosine production, and by suppressing pyroptosis. Transcriptome sequencing indicated that A2AR was reduced in ischemic flaps. Inhibition of A2AR impairs angiogenesis, promotes oxidative stress and pyroptosis, thereby exacerbating ischemia in the flaps. FIR irradiation attenuates pyroptosis through the A2AR/EPAC1/Rap1 pathway, thereby mitigating ischemia in the flaps caused by A2AR deficiency. Furthermore, KEGG pathway analysis revealed that the calcium signaling pathway and transient receptor potential channels play a critical role in ischemic flaps. Silencing TRPV3 in both mice and endothelial cells revealed that FIR upregulated TRPV3 expression, promoted extracellular Ca<sup>2+</sup> influx, triggered ATP conversion to adenosine, and subsequently activated A2AR. Overall, this study provides new insights into the therapeutic mechanisms of FIR irradiation in ischemic flaps, offering potential targets for improving the treatment of ischemic flap pathology.</div></div>","PeriodicalId":9902,"journal":{"name":"Cellular signalling","volume":"139 ","pages":"Article 112299"},"PeriodicalIF":3.7,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145699885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
M6A reader IGF2BP3 stabili1zes SLC7A11 to antagonize ferroptosis and promote gastric tumorigenesis M6A阅读器IGF2BP3稳定SLC7A11拮抗铁下垂,促进胃肿瘤发生。
IF 3.7 2区 生物学 Q2 CELL BIOLOGY Pub Date : 2025-12-04 DOI: 10.1016/j.cellsig.2025.112295
Yan Yang , Hong Ye , Shuming Qin , Min Lin , Yixiao Liu , Xiaomei Li
The RNA-binding protein IGF2BP3 is implicated in gastric cancer (GC) progression, yet its mechanisms remain incompletely understood. Here, we demonstrate that IGF2BP3 is highly expressed in GC tissues and correlates with poor prognosis. Clinical analyses revealed elevated IGF2BP3 levels in tumors compared to adjacent tissues, with overexpression linked to advanced pathological grading. Functional studies in GC cells showed that IGF2BP3 knockdown suppressed proliferation, migration, invasion, and G1/S cell cycle transition, while its overexpression promoted oncogenic phenotypes. In vivo xenograft experiments confirmed IGF2BP3's tumor-promoting role, with IGF2BP3 knockdown reducing tumor growth and Ki67 expression, whereas overexpression enhanced these parameters. Mechanistically, IGF2BP3 regulated ferroptosis by modulating mitochondrial morphology, intracellular iron accumulation, glutathione depletion, reactive oxygen species (ROS), and lipid peroxidation. Furthermore, IGF2BP3 stabilized SLC7A11 mRNA via N6-methyladenosine (m6A)-dependent mechanisms, as evidenced by reduced mRNA stability upon IGF2BP3 depletion and direct validation of m6A modifications on SLC7A11. Global m6A levels were also influenced by IGF2BP3 expression. Our findings establish IGF2BP3 as a multifaceted oncoprotein driving GC progression through cell cycle dysregulation, ferroptosis suppression, and m6A-mediated SLC7A11 stabilization, providing novel therapeutic targets for GC intervention.
rna结合蛋白IGF2BP3与胃癌(GC)进展有关,但其机制尚不完全清楚。本研究表明IGF2BP3在胃癌组织中高表达,并与不良预后相关。临床分析显示,与邻近组织相比,肿瘤中IGF2BP3水平升高,过度表达与晚期病理分级有关。在GC细胞中的功能研究表明,IGF2BP3敲低抑制增殖、迁移、侵袭和G1/S细胞周期转变,而其过表达促进致癌表型。体内异种移植实验证实了IGF2BP3的促瘤作用,IGF2BP3敲低可降低肿瘤生长和Ki67的表达,而过表达可增强这些参数。从机制上讲,IGF2BP3通过调节线粒体形态、细胞内铁积累、谷胱甘肽耗竭、活性氧(ROS)和脂质过氧化来调节铁下垂。此外,IGF2BP3通过n6 -甲基腺苷(m6A)依赖机制稳定SLC7A11 mRNA,这可以通过IGF2BP3耗用降低mRNA稳定性和m6A修饰SLC7A11的直接验证来证明。全球m6A水平也受IGF2BP3表达的影响。我们的研究结果表明,IGF2BP3是一个多方面的癌蛋白,通过细胞周期失调、铁凋亡抑制和m6a介导的SLC7A11稳定来驱动GC进展,为GC干预提供了新的治疗靶点。
{"title":"M6A reader IGF2BP3 stabili1zes SLC7A11 to antagonize ferroptosis and promote gastric tumorigenesis","authors":"Yan Yang ,&nbsp;Hong Ye ,&nbsp;Shuming Qin ,&nbsp;Min Lin ,&nbsp;Yixiao Liu ,&nbsp;Xiaomei Li","doi":"10.1016/j.cellsig.2025.112295","DOIUrl":"10.1016/j.cellsig.2025.112295","url":null,"abstract":"<div><div>The RNA-binding protein IGF2BP3 is implicated in gastric cancer (GC) progression, yet its mechanisms remain incompletely understood. Here, we demonstrate that IGF2BP3 is highly expressed in GC tissues and correlates with poor prognosis. Clinical analyses revealed elevated IGF2BP3 levels in tumors compared to adjacent tissues, with overexpression linked to advanced pathological grading. Functional studies in GC cells showed that IGF2BP3 knockdown suppressed proliferation, migration, invasion, and G1/S cell cycle transition, while its overexpression promoted oncogenic phenotypes. In vivo xenograft experiments confirmed IGF2BP3's tumor-promoting role, with IGF2BP3 knockdown reducing tumor growth and Ki67 expression, whereas overexpression enhanced these parameters. Mechanistically, IGF2BP3 regulated ferroptosis by modulating mitochondrial morphology, intracellular iron accumulation, glutathione depletion, reactive oxygen species (ROS), and lipid peroxidation. Furthermore, IGF2BP3 stabilized SLC7A11 mRNA via N6-methyladenosine (m6A)-dependent mechanisms, as evidenced by reduced mRNA stability upon IGF2BP3 depletion and direct validation of m6A modifications on SLC7A11. Global m6A levels were also influenced by IGF2BP3 expression. Our findings establish IGF2BP3 as a multifaceted oncoprotein driving GC progression through cell cycle dysregulation, ferroptosis suppression, and m6A-mediated SLC7A11 stabilization, providing novel therapeutic targets for GC intervention.</div></div>","PeriodicalId":9902,"journal":{"name":"Cellular signalling","volume":"139 ","pages":"Article 112295"},"PeriodicalIF":3.7,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145695907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CAFs-EVs-miR-6765-3p promotes malignant progression of colorectal cancer by regulating aerobic glycolysis mediated by the GNG7/mTOR pathway cafs - ev - mir -6765-3p通过调节GNG7/mTOR途径介导的有氧糖酵解促进结直肠癌的恶性进展
IF 3.7 2区 生物学 Q2 CELL BIOLOGY Pub Date : 2025-12-04 DOI: 10.1016/j.cellsig.2025.112297
Cheng Xi, Zheng Zhang, Nianyuan Ye, Haifeng Tang, Wei Ding, Yibo Wang
Recently, the signaling interactions between cancer cells and stromal cells within the tumor microenvironment (TME) have been extensively studied. Cancer-associated fibroblasts (CAFs) serve as critical stromal components in the TME. Numerous studies have shown that CAFs promote cancer progression by delivering microRNAs (miRNAs) to colorectal cancer (CRC) cells. In this study, miR-6765-3p was found to be overexpressed in extracellular vesicles (EVs) secreted by CAFs (CAFs-EVs) and could be transferred to CRC cells, thereby enhancing malignant cell phenotypes. Further experiments have demonstrated that miR-6765-3p directly targets the 3′-untranslated region (UTR) of G protein γ 7 (GNG7). Mechanistically, we have collaboratively demonstrated through cellular and animal experiments that the overexpression of GNG7 reduces CRC progression mediated by miR-6765-3p in CAFs-EVs. Furthermore, GNG7 has been elucidated to suppress CRC development by inhibiting the phosphorylation of proteins involved in the mTOR pathway. It is important to emphasize that the mTOR pathway plays a key role in regulating aerobic glycolysis processes in cancer. Consistently, our study further demonstrated that CAFs-EVs activate aerobic glycolysis via the mTOR pathway by suppressing GNG7 expression. In summary, our findings suggest that CAFs-EVs carrying miR-6765-3p promote the malignant progression of CRC by modulating the GNG7/mTOR pathway to stimulate aerobic glycolysis.
近年来,肿瘤微环境(tumor microenvironment, TME)内癌细胞与基质细胞之间的信号相互作用得到了广泛的研究。癌症相关成纤维细胞(CAFs)在TME中是关键的基质成分。大量研究表明,CAFs通过向结直肠癌(CRC)细胞传递microRNAs (miRNAs)来促进癌症进展。本研究发现,miR-6765-3p在CAFs分泌的细胞外囊泡(ev) (CAFs- ev)中过表达,并可转移到CRC细胞中,从而增强恶性细胞表型。进一步的实验表明,miR-6765-3p直接靶向G蛋白γ 7 (GNG7)的3 ' -未翻译区(UTR)。在机制上,我们通过细胞和动物实验共同证明了GNG7的过表达减少了由miR-6765-3p在cafs - ev中介导的CRC进展。此外,GNG7已被阐明通过抑制mTOR通路中蛋白的磷酸化来抑制结直肠癌的发展。值得强调的是,mTOR通路在调节癌症的有氧糖酵解过程中起着关键作用。与此一致,我们的研究进一步证明,cafs - ev通过抑制GNG7的表达,通过mTOR途径激活有氧糖酵解。总之,我们的研究结果表明,携带miR-6765-3p的cafs - ev通过调节GNG7/mTOR通路刺激有氧糖酵解来促进CRC的恶性进展。
{"title":"CAFs-EVs-miR-6765-3p promotes malignant progression of colorectal cancer by regulating aerobic glycolysis mediated by the GNG7/mTOR pathway","authors":"Cheng Xi,&nbsp;Zheng Zhang,&nbsp;Nianyuan Ye,&nbsp;Haifeng Tang,&nbsp;Wei Ding,&nbsp;Yibo Wang","doi":"10.1016/j.cellsig.2025.112297","DOIUrl":"10.1016/j.cellsig.2025.112297","url":null,"abstract":"<div><div>Recently, the signaling interactions between cancer cells and stromal cells within the tumor microenvironment (TME) have been extensively studied. Cancer-associated fibroblasts (CAFs) serve as critical stromal components in the TME. Numerous studies have shown that CAFs promote cancer progression by delivering microRNAs (miRNAs) to colorectal cancer (CRC) cells. In this study, miR-6765-3p was found to be overexpressed in extracellular vesicles (EVs) secreted by CAFs (CAFs-EVs) and could be transferred to CRC cells, thereby enhancing malignant cell phenotypes. Further experiments have demonstrated that miR-6765-3p directly targets the 3′-untranslated region (UTR) of G protein γ 7 (GNG7). Mechanistically, we have collaboratively demonstrated through cellular and animal experiments that the overexpression of GNG7 reduces CRC progression mediated by miR-6765-3p in CAFs-EVs. Furthermore, GNG7 has been elucidated to suppress CRC development by inhibiting the phosphorylation of proteins involved in the mTOR pathway. It is important to emphasize that the mTOR pathway plays a key role in regulating aerobic glycolysis processes in cancer. Consistently, our study further demonstrated that CAFs-EVs activate aerobic glycolysis via the mTOR pathway by suppressing GNG7 expression. In summary, our findings suggest that CAFs-EVs carrying miR-6765-3p promote the malignant progression of CRC by modulating the GNG7/mTOR pathway to stimulate aerobic glycolysis.</div></div>","PeriodicalId":9902,"journal":{"name":"Cellular signalling","volume":"139 ","pages":"Article 112297"},"PeriodicalIF":3.7,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145683936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selenium-binding protein 1 suppresses cell cycle progression via cyclin-dependent kinase 2 breakdown in colon carcinoma 硒结合蛋白1通过细胞周期蛋白依赖性激酶2分解抑制结肠癌细胞周期进程。
IF 3.7 2区 生物学 Q2 CELL BIOLOGY Pub Date : 2025-12-04 DOI: 10.1016/j.cellsig.2025.112296
Xiaotian Zhang , Dong Zhang , Qichang Liu , Zhipeng Cao , Ju Yang , Liang Li , Runqi Hong , Zhiqing Hu , Jiankang Zhu , Rui Chen , Gengming Niu , Shanliang Han , Chongwei Ke , Liang Chen
Selenium-binding protein 1 (SELENBP1) may act as a tumor suppressor gene in colorectal cancer (CRC). However, it remains unclear whether SELENBP1 regulates cell cycle progression governed by cyclin-dependent kinase 2 (CDK2). Herein, we validated the intracellular binding of SELENBP1 to CDK2, based on our previous observations. We investigated the regulatory effects of SELENBP1 on retinoblastoma protein (RB) signaling pathway activation and CDK2-mediated cell cycle progression. Finally, we explored the molecular mechanism through which SELENBP1 inhibited CDK2 expression. Both ectopically induced and endogenously expressed SELENBP1 bound to CDK2 in cultured CRC cells. SELENBP1 inhibited the expression of CDK2 and activated RB signaling. Studies have indicated that SELENBP1 inhibits the cell cycle and suppresses tumor growth. Mechanistic studies showed that SELENBP1 might suppress cancer cell growth by causing CDK2 breakdown via ubiquitination. We conclude that SELENBP1 plays a distinct role as a potential tumor suppressor-associated gene that blocks the interphase and mitosis continuum and suppresses tumor growth in CRC by inducing the ubiquitination-mediated degradation of CDK2.
硒结合蛋白1 (SELENBP1)可能在结直肠癌(CRC)中发挥肿瘤抑制基因的作用。然而,SELENBP1是否调控由周期蛋白依赖性激酶2 (cyclin-dependent kinase 2, CDK2)调控的细胞周期进程尚不清楚。在此,基于我们之前的观察,我们验证了SELENBP1与CDK2的细胞内结合。我们研究了SELENBP1对视网膜母细胞瘤蛋白(RB)信号通路激活和cdk2介导的细胞周期进程的调节作用。最后,我们探讨了SELENBP1抑制CDK2表达的分子机制。在体外培养的结直肠癌细胞中,硒bp1结合CDK2在体外诱导和内源性表达。SELENBP1抑制CDK2的表达,激活RB信号。研究表明,SELENBP1抑制细胞周期,抑制肿瘤生长。机制研究表明,SELENBP1可能通过泛素化作用导致CDK2分解,从而抑制癌细胞生长。我们得出结论,SELENBP1作为一种潜在的肿瘤抑制相关基因发挥着独特的作用,它通过诱导泛素化介导的CDK2降解,阻断结直肠癌的间期和有丝分裂连续体,抑制肿瘤生长。
{"title":"Selenium-binding protein 1 suppresses cell cycle progression via cyclin-dependent kinase 2 breakdown in colon carcinoma","authors":"Xiaotian Zhang ,&nbsp;Dong Zhang ,&nbsp;Qichang Liu ,&nbsp;Zhipeng Cao ,&nbsp;Ju Yang ,&nbsp;Liang Li ,&nbsp;Runqi Hong ,&nbsp;Zhiqing Hu ,&nbsp;Jiankang Zhu ,&nbsp;Rui Chen ,&nbsp;Gengming Niu ,&nbsp;Shanliang Han ,&nbsp;Chongwei Ke ,&nbsp;Liang Chen","doi":"10.1016/j.cellsig.2025.112296","DOIUrl":"10.1016/j.cellsig.2025.112296","url":null,"abstract":"<div><div>Selenium-binding protein 1 (SELENBP1) may act as a tumor suppressor gene in colorectal cancer (CRC). However, it remains unclear whether SELENBP1 regulates cell cycle progression governed by cyclin-dependent kinase 2 (CDK2). Herein, we validated the intracellular binding of SELENBP1 to CDK2, based on our previous observations. We investigated the regulatory effects of SELENBP1 on retinoblastoma protein (RB) signaling pathway activation and CDK2-mediated cell cycle progression. Finally, we explored the molecular mechanism through which SELENBP1 inhibited CDK2 expression. Both ectopically induced and endogenously expressed SELENBP1 bound to CDK2 in cultured CRC cells. SELENBP1 inhibited the expression of CDK2 and activated RB signaling. Studies have indicated that SELENBP1 inhibits the cell cycle and suppresses tumor growth. Mechanistic studies showed that SELENBP1 might suppress cancer cell growth by causing CDK2 breakdown via ubiquitination. We conclude that SELENBP1 plays a distinct role as a potential tumor suppressor-associated gene that blocks the interphase and mitosis continuum and suppresses tumor growth in CRC by inducing the ubiquitination-mediated degradation of CDK2.</div></div>","PeriodicalId":9902,"journal":{"name":"Cellular signalling","volume":"139 ","pages":"Article 112296"},"PeriodicalIF":3.7,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145695919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cellular signalling
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1